Delayed Stroke Diagnosis: Breach, Causation, and the Treatment Window

A delayed stroke diagnosis is not, by itself, a case. The question for both plaintiff and defense is whether the delay crossed from diagnostic uncertainty — an ordinary feature of emergency medicine — into conduct that fell below the standard of care, and whether that conduct deprived the patient of treatment that would have changed the outcome. Both elements have to be present. Either one, standing alone, produces a weak claim or an overconfident defense.

The Treatment Windows

Modern stroke care is organized around time. During a large-vessel occlusion, roughly 1.9 million neurons are lost per minute of untreated ischemia.¹ Guideline bodies have translated that biology into defined windows that now form the backbone of standard-of-care analysis.

The 2019 AHA/ASA Guidelines recommend intravenous alteplase for eligible patients within 4.5 hours of symptom onset or last known well, with a door-to-needle benchmark of 60 minutes.² Tenecteplase has since emerged as an alternative with comparable efficacy and a simpler administration profile.

For large-vessel occlusion (LVO), mechanical thrombectomy is recommended up to 24 hours from last known well in properly selected patients. The extended window rests on the DAWN and DEFUSE 3 trials, which established benefit beyond six hours in patients with favorable perfusion imaging — meaning salvageable tissue despite prolonged symptoms.³⁴ A subsequent individual-patient-data meta-analysis (AURORA) strengthened that signal across the pooled late-window cohort.⁵ The 2023 AHA/ASA Focused Update reaffirmed this framework.

These windows are the first fact an attorney should pin down. A delay that pushes a patient past an open window — when they would otherwise have qualified — is where the breach and causation analyses begin to converge.

The Standard of Care

Standard of care for stroke evaluation is shaped by clinical guidelines, institutional protocols, and the resources of the facility where the patient presented. The core expectations:

• Recognition. Emergency providers are expected to identify both classic presentations — facial droop, arm weakness, speech difficulty — and the less obvious ones, including isolated vertigo, visual field cuts, and acute confusion.
• Imaging. A non-contrast head CT should be obtained and read within 45 minutes of arrival in a suspected stroke. CT angiography is indicated when large-vessel occlusion is on the differential and thrombectomy is an option.
• Team activation. Hospitals with stroke programs are expected to run a "code stroke" pathway that mobilizes the necessary personnel in parallel, not serially.
• Transfer. Facilities without thrombectomy capability are expected to identify LVO patients and initiate transfer without avoidable delay. The drip-and-ship model — thrombolysis locally, thrombectomy at a comprehensive stroke center — is the accepted approach in most regions.

Deviation from any one of these expectations does not establish liability. The question is whether the deviation fell below what a reasonably prudent provider would have done under the same circumstances — with the same history, the same examination, and the same resources.

Recurring Patterns in Delayed-Diagnosis Claims

Several fact patterns recur in the cases I review.

Atypical presentation misread as a benign condition. Posterior circulation strokes — brainstem and cerebellar — often present with dizziness, nausea, and gait instability, easily attributed to vestibular neuritis or a viral syndrome. Young patients without traditional vascular risk factors further soften clinical suspicion. Whether the misread was reasonable depends on the full picture: documented examination findings, red flags that should have prompted imaging (HINTS testing, new headache, directional nystagmus), and how the differential was worked.

System and workflow failures. Sometimes the diagnosis is correct but the treatment is late: slow imaging turnaround, delayed neurology consultation, protracted transfer logistics. The ESCAPE workflow analysis quantified what these minutes are worth — each thirty-minute reduction in door-to-reperfusion time meaningfully shifted outcomes.⁶ These cases often place institutional process on the same footing as individual judgment.

True mimics. Complex migraine, postictal (Todd's) paralysis, hypoglycemia, and conversion disorder can all resemble acute stroke. A period of diagnostic uncertainty is not, in itself, substandard care. What matters is whether the differential was articulated and worked in a defensible sequence.

The Causation Burden

A breach is not enough. The plaintiff must show that timely diagnosis and treatment would, to a reasonable degree of medical certainty, have produced a better outcome. In stroke litigation, that analysis turns on a small set of specific questions:

• Was the patient within an open treatment window at the time care was sought?
• Would the patient have been a candidate for thrombolysis or thrombectomy — or were there contraindications that would have excluded them regardless? The interaction matters: the literature on bridging thrombolysis plus thrombectomy versus thrombectomy alone remains actively contested, and a causation theory that depends on one specific treatment pathway should be tested against the evidence for that pathway in isolation.⁷
• What does the trial literature predict about the likelihood of an improved outcome with timely treatment in a patient of this profile?
• Was the infarct already completed — tissue already lost — by the time of presentation, such that no intervention could have altered the trajectory?

Imaging is often where causation is decided. Perfusion studies, ASPECTS scores, and infarct core volumes can demonstrate that substantial injury had already occurred before the alleged delay began. They can also demonstrate the opposite — that a salvageable mismatch existed and was allowed to evolve. A thoughtful review does not assume either.

Reading the Record

The useful work in a delayed-diagnosis case is mostly in the record itself. A careful review pins down:

• Documented symptom onset and the time of last known well
• Triage vitals, presenting complaint, and initial ED examination
• Timing and interpretation of each imaging study, including any perfusion data
• Treatment eligibility — age, anticoagulation status, prior infarct, contraindications
• The clinical trajectory from presentation through final neurological outcome, and how that trajectory compares to what timely treatment would have predicted

Most stroke claims resolve, one way or another, once those elements are placed next to one another in order. A delay that looks damning in the complaint sometimes dissolves against imaging showing a completed infarct on arrival. A defense that looked strong sometimes collapses against a nursing note that fixes last-known-well earlier than the chart had assumed. The record usually knows.

References

Footnotes

1. Saver JL. Time is brain — quantified. Stroke. 2006;37(1):263–266. doi:10.1161/01.STR.0000196957.55928.ab ↩

2. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211 ↩

3. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct (DAWN). N Engl J Med. 2018;378(1):11–21. doi:10.1056/NEJMoa1706442 ↩

4. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging (DEFUSE 3). N Engl J Med. 2018;378(8):708–718. doi:10.1056/NEJMoa1713973 ↩

5. Jovin TG, Nogueira RG, Lansberg MG, et al. Thrombectomy for anterior circulation stroke beyond 6 hours (AURORA): a systematic review and individual patient data meta-analysis. Lancet. 2022;399(10321):249–258. doi:10.1016/S0140-6736(21)01341-6 ↩

6. Menon BK, Sajobi TT, Zhang Y, et al. Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the ESCAPE Randomized Controlled Trial. Circulation. 2016;133(23):2279–2286. doi:10.1161/CIRCULATIONAHA.115.019983 ↩

7. Mistry EA, Mistry AM, Nakawah MO, et al. Mechanical Thrombectomy Outcomes With and Without Intravenous Thrombolysis in Stroke Patients: A Meta-Analysis. Stroke. 2017;48(9):2450–2456. doi:10.1161/STROKEAHA.117.017320 ↩